India has been assisting Belarus Government in establishing a pharmaceutical enterprise called JivaPharm which will be built in Kolyadichi in Minsk to make antiretroviral medications.
By Team ABLE
According to The Belarusian Telegraph Agency (BelTA), a Belarusian-Indian pharmaceutical enterprise JivaPharm will be established in Kolyadichi located in Minsk, Belarus. The enterprise will occupy 4.63ha. The construction process will be split into three stages. During the first stage a three-storey building will be erected to make antiretroviral medications to treat people suffering from AIDS, hepatitis B, and other diseases that the Belarus Healthcare Ministry closely monitors.
The building will house manufacturing facilities and warehouses, a modern lab to design new products, and a proprietary quality control division. The building has been designed bearing in mind the logical sequence of pharmaceutical operations and the cleanliness requirements in order to rule out the traversal of human and material traffic. This part of the enterprise is supposed to start working in 2017-2018. In the next phase the enterprise will start making medications for general therapeutic purposes and for treating oncological pathologies. A logistics hub will also be set up, says the news report.
Once the enterprise is fully operational, it is supposed to make 22.5 million pills of antiretroviral medications, 11 million pills for general therapeutic purposes, and 800,000 capsules per annum. Apart from commercial value the project offers social one: medications for treating hepatitis and oncological diseases will become more affordable. The cost of medications made by JivaPharm will be 5-7 times below the market prices. Chairman of the Council of the Republic of the National Assembly of Belarus Mikhail Myasnikovich noted that a package of documents on creating a common market of medications in the Eurasian Economic Union had been signed recently. It is good news for investors and Belarusian manufacturers since they will be able to sell their products in the Eurasian Economic Union using simplified schemes. Ambassador Extraordinary and Plenipotentiary of India to Belarus Pankaj Saxena underlined that pharmaceutics is an important industry both for India and Belarus.
Belarusian and Indian companies intend on working together to make high-quality inexpensive medications. The enterprise to be built in Kolyadichi will open up new opportunities. It is possible that Indian private sector may invest not only in pharmaceutics but other industries, too. The report has indicated that other pharmaceutical factories will be built with India's assistance in Belarus soon.
(Source: BelTA http://eng.belta.by/economics/view/plans-to-build-belarusian-indian-pharmaceutical-enterprise-in-kolyadichi-93808-2016/)